🇦🇪 Yartemlea in United Arab Emirates

Yartemlea (NARSOPLIMAB) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Marketing authorisation holder: OMEROS CORP
  • Status: likely_approved

Yartemlea in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Arab Emirates

Frequently asked questions

Is Yartemlea approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Yartemlea in United Arab Emirates?

OMEROS CORP holds the UAE marketing authorisation.